Skip to main content

Obsessive–Compulsive Disorders

  • Chapter
  • First Online:
Psychiatric Drugs in Children and Adolescents

Abstract

Obsessive–compulsive disorders (OCD) are recurrent and persistent thoughts, behavioral patterns, ideas, and impulses/urges that impose themselves against internal resistance and are experienced by the patient as senseless (for specification of insight in the disorder, please see below), excessive, or distressing.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

Literature

  • AACAP Official Action (2012) Practice parameter for the assessment and treatment of children and adolescents with obsessive-compulsive disorder. J Am Acad Child Psychiatry 51:98–113

    Article  Google Scholar 

  • Abramowitz JS, Taylor S, McKay D (2005) Potentials and limitations of cognitive treatments for obsessive-compulsive disorder. Cogn Behav Ther 34:140–147

    Article  PubMed  Google Scholar 

  • Alaghband-Rad J, Hakimshooshtary M (2009) A randomized controlled clinical trial of citalopram versus fluoxetine in children and adolescents with obsessive-compulsive disorder (OCD). Eur Child Adolesc Psychiatry 18:131–135

    Article  PubMed  Google Scholar 

  • American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, 5th edn (DSM-5TM). American Psychiatric Publishing, Washington/London

    Google Scholar 

  • Blier P, Habib R, Flament F (2006) Pharmacotherapies in the management of obsessive-compulsive disorder. Can J Psychiatry 51:417–430

    PubMed  Google Scholar 

  • Bloch MH, Landeros-Weisenberger A, Kelmendi B, Coric V, Bracken MB, Leckman JF (2006) A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder. Mol Psychiatry 11:622–632

    Article  CAS  PubMed  Google Scholar 

  • Bridge JA, Iyengar S, Salary CB, Barbe RP, Birmaher B, Pincus HA, Ren L, Brent DA (2007) Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. JAMA 297:1683–1696

    Article  CAS  PubMed  Google Scholar 

  • Cook EH, Wagner KD, March JS, Biedermann J, Landau P, Wolkow R, Messig M (2001) Long-term sertraline treatment of children and adolescents with obsessive-compulsive disorder. J Am Acad Child Psychiatry 40:1174–1181

    Article  Google Scholar 

  • DeVeaugh-Geiss J, Moroz G, Biederman J, Cantwell D, Fontaine R, Greist JH, Reichler R, Katz R, Landau P (1992) Clomipramine hydrochloride in childhood and adolescent obsessive-compulsive disorder – a multicenter trial. J Am Acad Child Psychiatry 31:45–49

    Article  CAS  Google Scholar 

  • Diniz JB, Shavitt RG, Fossaluza V, Koran L, Pereira CAD, Miguel EC (2011) A double-blind, randomized, controlled trial of fluoxetine plus quetiapine or clomipramine versus fluoxetine plus placebo for obsessive-compulsive disorder. J Clin Psychopharmacol 31:763–768

    Article  CAS  PubMed  Google Scholar 

  • Dold M, Aigner M, Lanzenberger R, Kasper S (2013) Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a meta-analysis of double-blind, randomized, placebo-controlled trials. Int J Neuropsychopharmacol 16:557–574

    Article  CAS  PubMed  Google Scholar 

  • Franklin ME, Sapyta J, Freeman JB, Khanna M, Compton S, Almirall D, Moore P, Choate-Summers M, Garcia A, Edson AL, Foa EB, March JS (2011) Cognitive behavior therapy augmentation of pharmacotherapy in pediatric obsessive-compulsive disorder: the Pediatric OCD Treatment Study II (POTS II) randomized controlled trial. JAMA 306:1224–1232

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Freeman JB, Choate-Summers ML, Moore PS, Garcia AM, Sapyta JJ, Leonard HL, Franklin ME (2007) Cognitive behavioral treatment for young children with obsessive-compulsive disorder. Biol Psychiatry 61:337–343

    Article  PubMed Central  PubMed  Google Scholar 

  • Freeman J, Garcia A, Frank H, Benito K, Conelea C, Walther M, Edmunds J (2014) Evidence base update for psychosocial treatments for pediatric obsessive-compulsive disorder. J Clin Child Adolesc Psychol 43:7–26

    Google Scholar 

  • Geller DA, Biedermann J, Stewart SE, Mullin B, Martin A, Spencer T (2003) Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder. Am J Psychiatry 160:1919–1929

    Article  PubMed  Google Scholar 

  • Gentile S (2011) Efficacy of antidepressant medications in children and adolescents with obsessive-compulsive disorder: a systematic appraisal. J Clin Psychopharmacol 31:625–632

    Article  CAS  PubMed  Google Scholar 

  • Leonard HL, Swedo SE, Rapoport JL, Koby EV, Lenane MC, Cheslow DL, Hamburger SD (1989) Treatment of obsessive-compulsive disorder with clomipramine and desipramine in children and adolescents. A double-blind crossover comparison. Arch Gen Psychiatry 46:1088–1092

    Article  CAS  PubMed  Google Scholar 

  • Manusco E, Faro A, Joshi G, Geller DA (2010) Treatment of pediatric obsessive-compulsive disorder: a review. J Child Adolesc Psychopharmacol 20:299–308

    Article  Google Scholar 

  • March JS, Franklin ME, Leonard H, Garcia A, Moore P, Freeman J, Foa E (2007) Tics moderate treatment outcome with sertraline but not cognitive-behavior therapy in pediatric obsessive-compulsive disorder. Biol Psychiatry 61:344–347

    Article  PubMed  Google Scholar 

  • McDougle CJ, Epperson CN, Pelton GH, Wasylink S, Price LH (2000) A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder. Arch Gen Psychiatry 57:794–801

    Article  CAS  PubMed  Google Scholar 

  • National Institute for Health and Clinical Excellence (2005) Obsessive-compulsive disorder. Quick reference guide. http://guidance.nice.org.uk

  • O’Kearney RT, Anstey KJ, von Sanden C, Hunt A (2006) Behavioural and cognitive behavioural therapy for obsessive compulsive disorder in children and adolescents. Cochrane Database Syst Rev 4:CD004856

    Google Scholar 

  • Pediatric OCD Treatment Study (POTS) Team (2004) Cognitive-behavior therapy sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial. JAMA 292:1969–1976

    Article  Google Scholar 

  • Scahill L, Riddle MA, McSwiggin-Hardin M, Ort SI, King RA, Goodman WK, Cicchetti D, Leckman JF (1997) Children’s Yale-Brown Obsessive Compulsive Scale: reliability and validity. J Am Acad Child Psychiatry 36:844–852

    Article  CAS  Google Scholar 

  • Shalev I, Sulkowski ML, Geffken GR, Rickets EJ, Murphy TK, Storch EA (2009) Long-term durability of cognitive behavioral therapy gains for pediatric obsessive-compulsive disorder. J Am Acad Child Psychiatry 48:766–767

    Article  Google Scholar 

  • Soomro GM, Altman D, Rajagopal S, Oakley-Browne M (2008) Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD).Cochrane Database Syst Rev (1):CD001765

    Google Scholar 

  • Stewart SE, Hezel D, Stachon AC (2012) Assessment and medication management of paediatric obsessive-compulsive disorder. Drugs 72:881–893

    Article  CAS  PubMed  Google Scholar 

  • Thomsen PH (2013) Obsessive-compulsive disorders. Eur Child Adolesc Psychiatry 22:S23–S28

    Article  PubMed  Google Scholar 

  • Walitza S, Melfsen S, Jans T, Zellmann H, Wewetzer C, Warnke A (2011) Obsessive-compulsive disorder in children and adolescents. Dtsch Arztebl Int 108:173–179

    PubMed Central  PubMed  Google Scholar 

  • Watson HJ, Rees CS (2008) Meta-analysis of randomized, controlled treatment trials for pediatric obsessive-compulsive disorder. J Child Psychol Psychiatry 49:489–498

    Article  PubMed  Google Scholar 

  • World Health Organization (1996) Multiaxial classification of child and adolescent psychiatric disorders. The ICD – 10 classification of mental and behavioral disorders in children and adolescents. Cambridge University Press, Cambridge

    Book  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Christoph Wewetzer MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Wien

About this chapter

Cite this chapter

Wewetzer, C., Walitza, S. (2014). Obsessive–Compulsive Disorders. In: Gerlach, M., Warnke, A., Greenhill, L. (eds) Psychiatric Drugs in Children and Adolescents. Springer, Vienna. https://doi.org/10.1007/978-3-7091-1501-5_21

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-1501-5_21

  • Published:

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-7091-1500-8

  • Online ISBN: 978-3-7091-1501-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics